Evolus, Inc. (EOLS) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $5.75 (-4.08%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 4, 2026 | Uy Ear | Mizuho Securities | $15.00 | +160.6% |
| Jan 13, 2026 | Annabel Samimy | Stifel Nicolaus | $17.00 | +195.4% |
| Dec 1, 2025 | Vamil Divan | Mizuho Securities | $19.00 | +230.1% |
| Oct 3, 2024 | Douglas Tsao | H.C. Wainwright | $27.00 | +369.2% |
| Sep 13, 2024 | Balaji Prasad | Barclays | $20.00 | +247.5% |
| Sep 13, 2024 | Vamil Divan | Mizuho Securities | $25.00 | +334.4% |
| Jan 29, 2024 | Balaji Prasad | Barclays | $16.00 | +178.0% |
Top Analysts Covering EOLS
EOLS vs Sector & Market
| Metric | EOLS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +160.6% | +16316.0% | +17.1% |
| P/E Ratio | -6.58 | 3.02 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $76M | $79M | $82M | 2 |
| 2026-12-31 | $328M | $330M | $331M | 5 |
| 2027-03-31 | $79M | $82M | $85M | 3 |
| 2027-06-30 | $92M | $96M | $98M | 2 |
| 2027-09-30 | $89M | $92M | $95M | 2 |
| 2027-12-31 | $112M | $117M | $120M | 3 |
| 2028-03-31 | $94M | $98M | $101M | 2 |
| 2028-06-30 | $109M | $113M | $117M | 1 |
| 2028-09-30 | $103M | $107M | $110M | 1 |
| 2028-12-31 | $131M | $136M | $140M | 2 |
| 2029-12-31 | $521M | $530M | $538M | 3 |
| 2030-12-31 | $583M | $593M | $602M | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.04 | $-0.04 | $-0.04 | 1 |
| 2026-12-31 | $-0.15 | $-0.09 | $-0.03 | 4 |
| 2027-03-31 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2027-06-30 | $0.04 | $0.04 | $0.04 | 1 |
| 2027-09-30 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-12-31 | $0.15 | $0.16 | $0.17 | 1 |
| 2028-03-31 | $0.03 | $0.03 | $0.03 | 1 |
| 2028-06-30 | $0.12 | $0.12 | $0.13 | 1 |
| 2028-09-30 | $0.08 | $0.08 | $0.08 | 1 |
| 2028-12-31 | $0.22 | $0.23 | $0.24 | 1 |
| 2029-12-31 | $1.24 | $1.26 | $1.29 | 4 |
| 2030-12-31 | $1.60 | $1.64 | $1.67 | 2 |
Frequently Asked Questions
What is the analyst consensus for EOLS?
The consensus among 3 analysts covering Evolus, Inc. (EOLS) is Buy with an average price target of $15.00.
What is the highest price target for EOLS?
The highest price target for EOLS is $27.00, set by Douglas Tsao at H.C. Wainwright on 2024-10-03.
What is the lowest price target for EOLS?
The lowest price target for EOLS is $15.00, set by Uy Ear at Mizuho Securities on 2026-02-04.
How many analysts cover EOLS?
3 analysts have issued ratings for Evolus, Inc. in the past 12 months.
Is EOLS a buy or sell right now?
Based on 3 analyst ratings, EOLS has a consensus rating of Buy (2.00/5) with a +160.6% upside to the consensus target of $15.00.
What are the earnings estimates for EOLS?
Analysts estimate EOLS will report EPS of $-0.04 for the period ending 2026-09-30, with revenue estimated at $79M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.